Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2025-12-24 @ 3:44 PM
NCT ID:
NCT04497792
Eligibility Criteria:
Inclusion Criteria:
* signed inform concent
* stable coronary artery disease
* planned percutaneous coronary intervention
* diabetes mellitus
Exclusion Criteria:
* previously performed coronary revascularization
* glomerular filtration rate less than 45 ml/min
* intolerance to empagliflozin
* serum potassium more than 5/5 mmol/l
* heart failure (NYHA III-IV)
* congenital heart disease
* acute coronary syndrome less than 3 months before enrollment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04497792
Study Brief:
Protocol Section:
NCT04497792